Table 2

Cox regression models for OM, NRM, and relapse and logistic regression models for graft failure and aGVHD

Univariate models
Multivariate models*
OMNRMGraft failureaGvHD 2-4aGvHD 3-4RelapseOMNRMGraft failureaGvHD 2-4aGvHD 3-4Relapse
10 of 10 allele-matched; HLA-DPB1 permissive 
10 of 10 allele-matched; HLA-DPB1 nonpermissive 2.04 (1.26-3.30) 3.33 (1.58-7.01) 5.79 (0.74-45.4) 1.05 (0.52-2.11) 1.82 (0.49-6.74) 1.22 (0.69-2.16) 2.12 (1.23-3.64) 3.41 (1.45-8.02) NA§ 1.29 (0.58-2.87) 1.82 (0.49-6.73) NA 
    P .003 .002 .09 .88 .37 .40 .006 .005  .52 .37  
9 of 10 allele-matched; HLA-DPB1 permissive 1.32 (0.72-2.40) 2.48 (1.06-5.80) 2.21 (0.19-25.1) 1.83 (0.81-4.12) 5.02 (1.31-19.2) 1.21 (0.61-2.40) 1.38 (0.71-2.69) 2.14 (0.81-5.66) NA§ 1.75 (0.69-4.45) 5.01 (1.31-19.2) NA 
    P .36 .04 .52 .14 .02 .58 .33 .12  .24 .02  
9 of 10 allele-matched; HLA-DPB1 nonpermissive 2.29 (1.42-3.69) 4.18 (2.01-8.72) 6.84 (0.88-52.9) 1.86 (0.95-3.65) 4.17 (1.21-14.4) 1.25 (0.70-2.22) 2.21 (1.28-3.80) 3.69 (1.58-8.61) NA§ 2.11 (0.97-4.56) 4.15 (1.20-14.3) NA 
    P .001 < .001 .06 .07 .02 .44 .004 .002  .06 .02  
No more than 8 of 10 allele-matched; HLA-DPB1 irrespective 2.30 (1.43-3.71) 3.93 (1.88-8.23) 5.99 (0.76-47.0) 1.78 (0.90-3.53) 2.41 (0.67-8.68) 1.30 (0.74-2.31) 2.04 (1.18-3.54) 3.06 (1.30-7.19) NA§ 2.13 (0.97-4.65) 2.40 (0.66-8.65) NA 
    P .001 < .001 .09 .09 .18 .36 .01 .01  .06 .18  
Univariate models
Multivariate models*
OMNRMGraft failureaGvHD 2-4aGvHD 3-4RelapseOMNRMGraft failureaGvHD 2-4aGvHD 3-4Relapse
10 of 10 allele-matched; HLA-DPB1 permissive 
10 of 10 allele-matched; HLA-DPB1 nonpermissive 2.04 (1.26-3.30) 3.33 (1.58-7.01) 5.79 (0.74-45.4) 1.05 (0.52-2.11) 1.82 (0.49-6.74) 1.22 (0.69-2.16) 2.12 (1.23-3.64) 3.41 (1.45-8.02) NA§ 1.29 (0.58-2.87) 1.82 (0.49-6.73) NA 
    P .003 .002 .09 .88 .37 .40 .006 .005  .52 .37  
9 of 10 allele-matched; HLA-DPB1 permissive 1.32 (0.72-2.40) 2.48 (1.06-5.80) 2.21 (0.19-25.1) 1.83 (0.81-4.12) 5.02 (1.31-19.2) 1.21 (0.61-2.40) 1.38 (0.71-2.69) 2.14 (0.81-5.66) NA§ 1.75 (0.69-4.45) 5.01 (1.31-19.2) NA 
    P .36 .04 .52 .14 .02 .58 .33 .12  .24 .02  
9 of 10 allele-matched; HLA-DPB1 nonpermissive 2.29 (1.42-3.69) 4.18 (2.01-8.72) 6.84 (0.88-52.9) 1.86 (0.95-3.65) 4.17 (1.21-14.4) 1.25 (0.70-2.22) 2.21 (1.28-3.80) 3.69 (1.58-8.61) NA§ 2.11 (0.97-4.56) 4.15 (1.20-14.3) NA 
    P .001 < .001 .06 .07 .02 .44 .004 .002  .06 .02  
No more than 8 of 10 allele-matched; HLA-DPB1 irrespective 2.30 (1.43-3.71) 3.93 (1.88-8.23) 5.99 (0.76-47.0) 1.78 (0.90-3.53) 2.41 (0.67-8.68) 1.30 (0.74-2.31) 2.04 (1.18-3.54) 3.06 (1.30-7.19) NA§ 2.13 (0.97-4.65) 2.40 (0.66-8.65) NA 
    P .001 < .001 .09 .09 .18 .36 .01 .01  .06 .18  

NA indicates not applicable.

*

Multivariate models include sex, age, and CMV status of donor and patient, year of transplantation, use of ATG, disease group, stem cell source, conditioning regimen, and use of TBI.

TCE4-nonpermissive mismatches were considered in the combined group of GvH and HvG direction and confronted with permissive mismatches. Numbers were for 10 of 10 allele-matched pairs: n = 140 nonpermissive, n = 61 permissive; for 9 of 10 allele-matched pairs: n = 145 nonpermissive, n = 54 permissive; for ≤8 of 10 allele-matched pairs: n = 137.

TCE4-nonpermissive mismatches were considered only in the GvH direction and confronted with the combined group of TCE4-permissive mismatches and TCE4-nonpermissive mismatches in the HvG direction. Numbers were for 10 of 10 allele-matched pairs: n = 72 nonpermissive, n = 129 permissive; for 9 of 10 allele-matched pairs: n = 85 nonpermissive, n = 114 permissive; for ≤8 of 10 allele-matched pairs: n = 137.

§

Not applicable because the number of events in each subgroup was too limited to allow statistically meaningful analysis.

Not applicable because the P > .2 in univariate models.

Close Modal

or Create an Account

Close Modal
Close Modal